Lynne Sullivan Overview

  • Primary Position
  • Chief Financial...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size
  • 000.0

Lynne Sullivan General Information

Biography

Ms. Lynne Sullivan serves as Chief Financial Officer & Head of Corporate Development at Unity Biotechnology. She currently chairs the Audit Committees of Solid Bioscience, BiomX, and Inozyme Pharma. She was most recently CFO of Compass Therapeutics, a Cambridge-based Immuno Oncology company, and was SVP of Finance at Biogen, where she spent over a decade, with global responsibility for Corporate Finance, Financial Planning and Analysis and Corporate Tax. Formerly, she was the Vice President of Tax for EMD Serono and the Vice President of Tax for North America at Merck KgaA. She was also a Tax Partner at Arthur Anderson, where she led the North East Region's Tax Consulting Practice for the firm. She holds a B.S. in Accounting from Suffolk University and a M.S. in Taxation from Bentley College. She served as the Co-Chair of BIO's Finance and Tax Committee from 2007 through 2018 and was a Certified Public Accountant licensed in MA from 1991 through June of 2018.

Contact Information

Primary Position
Chief Financial Officer and Head of Corporate Development, Unity Biotechnology
Education
Bentley University, Master's
Suffolk University, BS (Bachelor of Science)
Gender
Female
Email
lytatevelitessecill@umdoloreeuf
Phone
+1 (650) 000-0000
Address
  • 285 East Grand Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000

Lynne Sullivan Positions (1)

Firm name Firm type Title Location Industry Since
Unity Biotechnology Company Chief Financial Officer and Head of Corporate Development South San Francisco, CA Biotechnology 0000-00-00

Lynne Sullivan Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Chardan Healthcare Acquisition Special Purpose Acquisition Company (SPAC) Acquired/Merged Corporate Backed or Acquired New York, NY 0000-00-0
Inozyme Pharma Drug Discovery Publicly Held Formerly VC-backed Boston, MA 0000-00-0
Solid Biosciences Biotechnology Publicly Held Formerly VC-backed Charlestown, MA 0000-00-0

Lynne Sullivan Lead Partner on Deals (2)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Solid Biosciences 30-Mar-2017 Later Stage VC (Series C) 0000 Completed Biotechnology Charlestown, MA
Solid GT 03-Nov-2015 00000 00000 00 000.00 Completed Biotechnology Cambridge, MA

Lynne Sullivan Network (73)

Board Members (48)

Name Company Representing Location From
Gbola Amusa MD BiomX BiomX Ness Ziona, Israel 0000-00-00
Ruchita Sinha Inozyme Pharma Sanofi Ventures Boston, MA 0000-00-00
0000 000000 Solid Biosciences Bain Capital Charlestown, MA 0000-00-00
0000000 000 resTORbio Self Boston, MA 0000-00-00
000000 0000 Inozyme Pharma Self Boston, MA 0000-00-00

Portfolio Executives (25)

Name Company Role Deal date Location
Carl Morris Ph.D Solid Biosciences Chief Scientific Officer 30-Mar-2017 Charlestown, MA
Alexander Cumbo Solid Biosciences Chief Executive Officer & Board Member 30-Mar-2017 Charlestown, MA
0000000 0 Solid Biosciences Chief Medical Officer 30-Mar-2017 Charlestown, MA
00000000 Solid Biosciences Chief Financial Officer, Finance & Chief Accounting Officer, Accounting 30-Mar-2017 Charlestown, MA
00000 000 Solid Biosciences Head of Corporate Strategy and Business Development 30-Mar-2017 Charlestown, MA

Lynne Sullivan FAQs

  • Who is Lynne Sullivan?

    Ms. Lynne Sullivan serves as Chief Financial Officer & Head of Corporate Development at Unity Biotechnology.

  • How much does Lynne Sullivan typically invest?

    Lynne Sullivan's median deal size is 000000.

  • What is Lynne Sullivan’s main position?

    Lynne Sullivan’s primary position is Chief Financial Officer and Head of Corporate Development.

  • What are the contact details for Lynne Sullivan?

    Lynne Sullivan’s email address is lyoccaecatcupidatat@nonproident,s and his phone number is +1 (650) 000-0000.

  • How many active board seats does Lynne Sullivan hold?

    Lynne Sullivan holds 3 board seats including Chardan Healthcare Acquisition, Inozyme Pharma, and Solid Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »